ProFound AI for Digital Breast Tomosynthesis
iCADProduct specifications |
Information source:
Vendor
Last updated: June 21, 2022 |
General | |
---|---|
Product name | ProFound AI for Digital Breast Tomosynthesis |
Company | iCAD |
Subspeciality | Breast |
Modality | Mammography |
Disease targeted | Breast cancer |
Key-features | Malignancy detection, calcification detection, certainty scoring, case scoring |
Suggested use | Before: adapting worklist order During: perception aid (prompting all abnormalities/results/heatmaps) |
Data characteristics | |
Population | Asymptomatic screening population |
Input | 3D Digital Breast Tomosynthesis |
Input format | DICOM |
Output | Leasion score with segmentation overlay, case score, choice in operating point (high/med/low) |
Output format | DICOM Structured Report, GSPS, Secondary Capture |
Technology | |
Integration | Integration in standard reading environment (PACS), Stand-alone third party application, Provides case score in worklist when applicable |
Deployment | Locally on dedicated hardware |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 03-2018 |
Distribution channels | Arterys, RMS Medical Devices, Sectra Amplifier Store, GE and local Distributors |
Countries present (clinical, non-research use) | 25 |
Paying clinical customers (institutes) | 1300 |
Research/test users (institutes) | 30+ |
Pricing | |
Pricing model | |
Based on | |
Evidence | |
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance |
|
Other relevant papers |